Valuation: Illumina, Inc.

Market Cap 29.32B 25.65B 23.65B 21.88B 41.53B 2,798B 42.23B 283B 111B 1,374B 110B 108B 4,760B P/E 2026 *
41.3x
P/E 2027 * 34.1x
Enterprise Value 29.84B 26.1B 24.07B 22.27B 42.27B 2,848B 42.98B 288B 113B 1,399B 112B 110B 4,845B EV / Sales 2026 *
6.53x
EV / Sales 2027 * 6.04x
Free-Float
75.39%
Yield 2026 *
-
Yield 2027 * -
1 day+3.17%
1 week+2.69%
Current month+10.20%
1 month+21.08%
3 months+56.68%
6 months+37.35%
Current year+47.73%
1 week 184.66
Extreme 184.66
196.66
1 month 157.63
Extreme 157.63
196.66
Current year 112.65
Extreme 112.65
196.66
1 year 88
Extreme 88
196.66
3 years 68.7
Extreme 68.7
196.66
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap.
06-30Free

Director

142 0.0001%
06-30Free

Director

167 0.0001%
06-30
Corvex Management LP
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+3.17%+2.69%+98.85%+5.69% 29.32B
+2.86%+0.24%+24.97%+2.14% 195B
-0.86%-3.39%-22.07%+24.23% 146B
+0.40%-0.33%-56.30%-13.96% 66.87B
-2.47%-3.22%+18.32%+1.19% 52.59B
+0.01%-1.72%-28.17%-30.86% 43.85B
+3.50%+2.22%+10.13%+14.18% 37.73B
+2.44%-0.57%+8.00%+42.77% 37.03B
+1.27%-0.56%-18.57%-3.41% 30.07B
+0.03%-1.32%-14.32%-18.74% 29.43B
Average +1.11%-1.49%+2.08%+2.32% 66.76B
Weighted average by Cap. +1.19%-1.64%+0.32%+5.03%

Financials

2026 *2027 *
Net sales 4.57B 4B 3.69B 3.41B 6.47B 436B 6.58B 44.15B 17.31B 214B 17.16B 16.79B 742B 4.83B 4.22B 3.89B 3.6B 6.84B 461B 6.95B 46.63B 18.28B 226B 18.12B 17.73B 784B
Net income 723M 633M 584M 540M 1.02B 69.05B 1.04B 6.99B 2.74B 33.91B 2.72B 2.66B 117B 869M 760M 701M 649M 1.23B 82.94B 1.25B 8.39B 3.29B 40.73B 3.26B 3.19B 141B
Net Debt 522M 457M 421M 390M 739M 49.82B 752M 5.04B 1.98B 24.47B 1.96B 1.92B 84.75B -160M -140M -129M -119M -226M -15.25B -230M -1.54B -605M -7.49B -600M -587M -25.94B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
09/07/26 $193.76 +3.17% 1,725,053
08/07/26 $187.81 -2.06% 2,650,616
07/07/26 $191.76 -1.32% 2,582,918
06/07/26 $194.33 +2.99% 2,103,315
02/07/26 $188.68 +2.60% 2,941,733
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
193.76USD
Average target price
155.63USD
Spread / Average Target
-19.68%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock